{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [],
   "source": [
    "ebaid = pd.read_csv(\"ebaid.csv\", sep=';')\n",
    "dataset = pd.read_csv(\"dataset.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ebaid</th>\n",
       "      <th>substance</th>\n",
       "      <th>dpublication</th>\n",
       "      <th>ddecision</th>\n",
       "      <th>therapiegebiet</th>\n",
       "      <th>manufacturer</th>\n",
       "      <th>brandname</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2011-10-01Abira</td>\n",
       "      <td>Abirateronacetat</td>\n",
       "      <td>1/2/12</td>\n",
       "      <td>3/29/12</td>\n",
       "      <td>onkologische_Erkrankungen</td>\n",
       "      <td>Janssen-Cilag_GmbH</td>\n",
       "      <td>Zytiga</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2013-01-15Abira</td>\n",
       "      <td>Abirateronacetat</td>\n",
       "      <td>4/15/13</td>\n",
       "      <td>7/4/13</td>\n",
       "      <td>onkologische_Erkrankungen</td>\n",
       "      <td>Janssen-Cilag_GmbH</td>\n",
       "      <td>Zytiga</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2017-12-15Abira</td>\n",
       "      <td>Abirateronacetat</td>\n",
       "      <td>3/15/18</td>\n",
       "      <td>6/7/18</td>\n",
       "      <td>onkologische_Erkrankungen</td>\n",
       "      <td>Janssen-Cilag_GmbH</td>\n",
       "      <td>Zytiga</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2012-10-01Aclid</td>\n",
       "      <td>Aclidiniumbromid</td>\n",
       "      <td>1/2/13</td>\n",
       "      <td>3/21/13</td>\n",
       "      <td>Krankheiten_des_Atmungssystems</td>\n",
       "      <td>Almirall_Hermal_GmbH</td>\n",
       "      <td>Eklira_Genuair_/Bretaris_Genuair</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2015-10-15Aclid</td>\n",
       "      <td>Aclidiniumbromid</td>\n",
       "      <td>1/15/16</td>\n",
       "      <td>4/7/16</td>\n",
       "      <td>Krankheiten_des_Atmungssystems</td>\n",
       "      <td>AstraZeneca_GmbH</td>\n",
       "      <td>Eklira_Genuair/Bretaris_Genuair</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             ebaid         substance dpublication ddecision  \\\n",
       "0  2011-10-01Abira  Abirateronacetat       1/2/12   3/29/12   \n",
       "1  2013-01-15Abira  Abirateronacetat      4/15/13    7/4/13   \n",
       "2  2017-12-15Abira  Abirateronacetat      3/15/18    6/7/18   \n",
       "3  2012-10-01Aclid  Aclidiniumbromid       1/2/13   3/21/13   \n",
       "4  2015-10-15Aclid  Aclidiniumbromid      1/15/16    4/7/16   \n",
       "\n",
       "                   therapiegebiet          manufacturer  \\\n",
       "0       onkologische_Erkrankungen    Janssen-Cilag_GmbH   \n",
       "1       onkologische_Erkrankungen    Janssen-Cilag_GmbH   \n",
       "2       onkologische_Erkrankungen    Janssen-Cilag_GmbH   \n",
       "3  Krankheiten_des_Atmungssystems  Almirall_Hermal_GmbH   \n",
       "4  Krankheiten_des_Atmungssystems      AstraZeneca_GmbH   \n",
       "\n",
       "                          brandname  \n",
       "0                            Zytiga  \n",
       "1                            Zytiga  \n",
       "2                            Zytiga  \n",
       "3  Eklira_Genuair_/Bretaris_Genuair  \n",
       "4   Eklira_Genuair/Bretaris_Genuair  "
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ebaid.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>substance</th>\n",
       "      <th>product</th>\n",
       "      <th>year</th>\n",
       "      <th>month</th>\n",
       "      <th>title</th>\n",
       "      <th>date_published</th>\n",
       "      <th>url</th>\n",
       "      <th>text_index</th>\n",
       "      <th>text</th>\n",
       "      <th>text_lower</th>\n",
       "      <th>label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>Basel – Der Schweizer Pharmakonzern Roche blei...</td>\n",
       "      <td>basel  der schweizer pharmakonzern roche bleib...</td>\n",
       "      <td>3.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>Der Pharmakonzern peilt im Gesamtjahr ein Umsa...</td>\n",
       "      <td>der pharmakonzern peilt im gesamtjahr ein umsa...</td>\n",
       "      <td>3.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>Zwischen Januar und September legte der Umsatz...</td>\n",
       "      <td>zwischen januar und september legte der umsatz...</td>\n",
       "      <td>3.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   index  substance   product  year  month  \\\n",
       "0      0  Alectinib  Alecensa  2017      5   \n",
       "1      1  Alectinib  Alecensa  2017      5   \n",
       "2      2  Alectinib  Alecensa  2017      5   \n",
       "\n",
       "                                title       date_published  \\\n",
       "0  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "1  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "2  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "\n",
       "                                                 url  text_index  \\\n",
       "0  https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "1  https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "2  https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "\n",
       "                                                text  \\\n",
       "0  Basel – Der Schweizer Pharmakonzern Roche blei...   \n",
       "1  Der Pharmakonzern peilt im Gesamtjahr ein Umsa...   \n",
       "2  Zwischen Januar und September legte der Umsatz...   \n",
       "\n",
       "                                          text_lower  label  \n",
       "0  basel  der schweizer pharmakonzern roche bleib...    3.0  \n",
       "1  der pharmakonzern peilt im gesamtjahr ein umsa...    3.0  \n",
       "2  zwischen januar und september legte der umsatz...    3.0  "
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['ebaid', 'substance', 'dpublication', 'ddecision',\n",
       "       'therapiegebiet', 'manufacturer', 'brandname'], dtype=object)"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ebaid.columns.values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Leftover: 9\n"
     ]
    }
   ],
   "source": [
    "ebaid_dict = {}\n",
    "for substance, eid in zip(ebaid['substance'].tolist(),zip(ebaid['ebaid'].tolist(),ebaid['dpublication'].tolist(),ebaid['ddecision'].tolist())):\n",
    "    ebaid_dict[substance] = eid\n",
    "\n",
    "ebaid_dict_2 = {} \n",
    "for product, eid in zip(ebaid['brandname'].tolist(),zip(ebaid['ebaid'].tolist(),ebaid['dpublication'].tolist(),ebaid['ddecision'].tolist())):\n",
    "    ebaid_dict_2[product] = eid\n",
    "\n",
    "counter = 0\n",
    "\n",
    "ebaid_list_0=[]\n",
    "ebaid_list_1=[]\n",
    "ebaid_list_2=[]\n",
    "dataset_short = pd.DataFrame()\n",
    "\n",
    "for i, (substance,product) in enumerate(zip(np.unique(dataset['substance'].tolist()),np.unique(dataset['product'].tolist()))):\n",
    "    try:\n",
    "        ebaid_list = ebaid_dict[substance]\n",
    "    except:\n",
    "        try:\n",
    "            ebaid_list = ebaid_dict_2[product]\n",
    "        except:\n",
    "            ebaid_list = [\"-\",\"-\",\"-\"]\n",
    "            counter+=1\n",
    "        \n",
    "    ebaid_list_0.append(ebaid_list[0])\n",
    "    ebaid_list_1.append(ebaid_list[1])\n",
    "    ebaid_list_2.append(ebaid_list[2])\n",
    "dataset_short['substance'] = np.unique(dataset['substance'].tolist())\n",
    "dataset_short['ebaid'] =   ebaid_list_0\n",
    "dataset_short['dpublication'] =   ebaid_list_1\n",
    "dataset_short['ddecision'] =   ebaid_list_2\n",
    "print(\"Leftover:\",counter)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>substance</th>\n",
       "      <th>product</th>\n",
       "      <th>year</th>\n",
       "      <th>month</th>\n",
       "      <th>title</th>\n",
       "      <th>date_published</th>\n",
       "      <th>url</th>\n",
       "      <th>text_index</th>\n",
       "      <th>text</th>\n",
       "      <th>text_lower</th>\n",
       "      <th>label</th>\n",
       "      <th>ebaid</th>\n",
       "      <th>dpublication</th>\n",
       "      <th>ddecision</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>Basel – Der Schweizer Pharmakonzern Roche blei...</td>\n",
       "      <td>basel  der schweizer pharmakonzern roche bleib...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-05-01Alect</td>\n",
       "      <td>8/1/17</td>\n",
       "      <td>10/19/17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>Der Pharmakonzern peilt im Gesamtjahr ein Umsa...</td>\n",
       "      <td>der pharmakonzern peilt im gesamtjahr ein umsa...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-05-01Alect</td>\n",
       "      <td>8/1/17</td>\n",
       "      <td>10/19/17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>Zwischen Januar und September legte der Umsatz...</td>\n",
       "      <td>zwischen januar und september legte der umsatz...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-05-01Alect</td>\n",
       "      <td>8/1/17</td>\n",
       "      <td>10/19/17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>2017</td>\n",
       "      <td>5</td>\n",
       "      <td>Neue Arzneimittel treiben Roche an</td>\n",
       "      <td>2018-10-17 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98565/N...</td>\n",
       "      <td>0</td>\n",
       "      <td>In einer Telefonkonferenz stellte Schwan klar,...</td>\n",
       "      <td>in einer telefonkonferenz stellte schwan klar ...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-05-01Alect</td>\n",
       "      <td>8/1/17</td>\n",
       "      <td>10/19/17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Tampa/Florida – Der PD-L1-Inhibitor Durvalumab...</td>\n",
       "      <td>tampaflorida  der pdl1inhibitor durvalumab der...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Bei einem Drittel aller Patienten mit NSCLC wi...</td>\n",
       "      <td>bei einem drittel aller patienten mit nsclc wi...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Die PACIFIC-Studie hat untersucht, ob in diese...</td>\n",
       "      <td>die pacificstudie hat untersucht ob in dieser ...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Die beiden primären Endpunkte der Studie waren...</td>\n",
       "      <td>die beiden primären endpunkte der studie waren...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Nach zwölf Monaten waren im Durvalumab-Arm noc...</td>\n",
       "      <td>nach zwölf monaten waren im durvalumabarm noch...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Eine lebensverlängernde Wirkung konnte (noch) ...</td>\n",
       "      <td>eine lebensverlängernde wirkung konnte noch ni...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Dies sind für ein fortgeschrittenes Bronchialk...</td>\n",
       "      <td>dies sind für ein fortgeschrittenes bronchialk...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>11</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Durvalumab verlängert progressionsfreies Überl...</td>\n",
       "      <td>2017-09-12 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/78195/L...</td>\n",
       "      <td>1</td>\n",
       "      <td>Die Verträglichkeit von Durvalumab war für die...</td>\n",
       "      <td>die verträglichkeit von durvalumab war für die...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>12</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Sacramento – Der monoklonale Antikörper Atezol...</td>\n",
       "      <td>sacramento  der monoklonale antikörper atezoli...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>13</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Atezolizumab bindet am Programmed Cell Death L...</td>\n",
       "      <td>atezolizumab bindet am programmed cell death l...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>14</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Der Antikörper gehört damit zu einer Gruppe vo...</td>\n",
       "      <td>der antikörper gehört damit zu einer gruppe vo...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>15</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab und Pembrolizumab sind bereits erfol...</td>\n",
       "      <td>nivolumab und pembrolizumab sind bereits erfol...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>16</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Jetzt liegen die Ergebnisse der entsprechenden...</td>\n",
       "      <td>jetzt liegen die ergebnisse der entsprechenden...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>17</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Eine Besonderheit der Studienergebnisse ist, d...</td>\n",
       "      <td>eine besonderheit der studienergebnisse ist da...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>18</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Atezolizumab wurde aufgrund der Ergebnisse der...</td>\n",
       "      <td>atezolizumab wurde aufgrund der ergebnisse der...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>19</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Checkpoint-Inhibitor Atezolizumab verlängert L...</td>\n",
       "      <td>2016-12-15 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/72033/C...</td>\n",
       "      <td>2</td>\n",
       "      <td>Atezolizumab ist deutlich besser verträglich a...</td>\n",
       "      <td>atezolizumab ist deutlich besser verträglich a...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>20</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>FDA und EMA warnen vor unkritischem Einsatz vo...</td>\n",
       "      <td>2018-06-06 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/95632/U...</td>\n",
       "      <td>4</td>\n",
       "      <td>Silver Spring/London – Die beiden Checkpointin...</td>\n",
       "      <td>silver springlondon  die beiden checkpointinhi...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>21</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>FDA und EMA warnen vor unkritischem Einsatz vo...</td>\n",
       "      <td>2018-06-06 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/95632/U...</td>\n",
       "      <td>4</td>\n",
       "      <td>Pembrolizumab und Atezolizumab verdanken ihre ...</td>\n",
       "      <td>pembrolizumab und atezolizumab verdanken ihre ...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>22</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>FDA und EMA warnen vor unkritischem Einsatz vo...</td>\n",
       "      <td>2018-06-06 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/95632/U...</td>\n",
       "      <td>4</td>\n",
       "      <td>Beide Studien verglichen die Checkpointinhibit...</td>\n",
       "      <td>beide studien verglichen die checkpointinhibit...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>23</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Tecentriq</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>FDA und EMA warnen vor unkritischem Einsatz vo...</td>\n",
       "      <td>2018-06-06 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/95632/U...</td>\n",
       "      <td>4</td>\n",
       "      <td>FDA und EMA warnen deshalb vor dem Einsatz der...</td>\n",
       "      <td>fda und ema warnen deshalb vor dem einsatz der...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Atez2</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>24</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck erhält EU-Zulassung für Bavencio</td>\n",
       "      <td>2017-09-22 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/79448/M...</td>\n",
       "      <td>5</td>\n",
       "      <td>Darmstadt – Der Darmstädter Chemie- und Pharma...</td>\n",
       "      <td>darmstadt  der darmstädter chemie und pharmako...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>25</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck erhält EU-Zulassung für Bavencio</td>\n",
       "      <td>2017-09-22 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/79448/M...</td>\n",
       "      <td>5</td>\n",
       "      <td>Erste Markteinführungen seien in Deutschland u...</td>\n",
       "      <td>erste markteinführungen seien in deutschland u...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>26</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck erhält EU-Zulassung für Bavencio</td>\n",
       "      <td>2017-09-22 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/79448/M...</td>\n",
       "      <td>5</td>\n",
       "      <td>Bavencio ist der größte Hoffnungsträger in der...</td>\n",
       "      <td>bavencio ist der größte hoffnungsträger in der...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>27</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck erhält EU-Zulassung für Bavencio</td>\n",
       "      <td>2017-09-22 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/79448/M...</td>\n",
       "      <td>5</td>\n",
       "      <td>Die EU-Freigabe des Medikaments, das Merck zus...</td>\n",
       "      <td>die eufreigabe des medikaments das merck zusam...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>28</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Warum die Krebsimmuntherapie nicht immer erfol...</td>\n",
       "      <td>2017-08-08 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/77491/W...</td>\n",
       "      <td>6</td>\n",
       "      <td>Bethesda – Ein aufwendiges Screening aller bek...</td>\n",
       "      <td>bethesda  ein aufwendiges screening aller beka...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>29</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Warum die Krebsimmuntherapie nicht immer erfol...</td>\n",
       "      <td>2017-08-08 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/77491/W...</td>\n",
       "      <td>6</td>\n",
       "      <td>Die Immuntherapie hat die Behandlung von Krebs...</td>\n",
       "      <td>die immuntherapie hat die behandlung von krebs...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>70</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Neue Zielstruktur für Immuntherapie von solide...</td>\n",
       "      <td>2012-06-03 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/50395/N...</td>\n",
       "      <td>11</td>\n",
       "      <td>Auch die Blockade der Interaktion von PD-1 mit...</td>\n",
       "      <td>auch die blockade der interaktion von pd1 mit ...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>71</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Neue Zielstruktur für Immuntherapie von solide...</td>\n",
       "      <td>2012-06-03 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/50395/N...</td>\n",
       "      <td>11</td>\n",
       "      <td>Die objektiven Ansprechraten lagen zwischen se...</td>\n",
       "      <td>die objektiven ansprechraten lagen zwischen se...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>72</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Neue Zielstruktur für Immuntherapie von solide...</td>\n",
       "      <td>2012-06-03 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/50395/N...</td>\n",
       "      <td>11</td>\n",
       "      <td>Der Anti-PD-1-Antikörper sei im allgemeinen gu...</td>\n",
       "      <td>der antipd1antikörper sei im allgemeinen gut v...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>73</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck bleibt optimistisch für 2019</td>\n",
       "      <td>2018-10-16 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98519/M...</td>\n",
       "      <td>12</td>\n",
       "      <td>Darmstadt – Der Darmstädter Merck-Konzern setz...</td>\n",
       "      <td>darmstadt  der darmstädter merckkonzern setzt ...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>74</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck bleibt optimistisch für 2019</td>\n",
       "      <td>2018-10-16 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98519/M...</td>\n",
       "      <td>12</td>\n",
       "      <td>Ab dem kommenden Jahr erwarte der Dax-Konzern ...</td>\n",
       "      <td>ab dem kommenden jahr erwarte der daxkonzern s...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>75</td>\n",
       "      <td>Avelumab</td>\n",
       "      <td>Bavencio</td>\n",
       "      <td>2017</td>\n",
       "      <td>10</td>\n",
       "      <td>Merck bleibt optimistisch für 2019</td>\n",
       "      <td>2018-10-16 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/98519/M...</td>\n",
       "      <td>12</td>\n",
       "      <td>In seinem zuletzt schwächelnden Geschäft mit S...</td>\n",
       "      <td>in seinem zuletzt schwächelnden geschäft mit s...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2017-10-01Avelu</td>\n",
       "      <td>1/2/18</td>\n",
       "      <td>3/16/18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>76</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Berlin – Schnellere Arzttermine für gesetzlich...</td>\n",
       "      <td>berlin  schnellere arzttermine für gesetzlich ...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>77</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Zu den wesentlichen Regelungen des Gesetzes ge...</td>\n",
       "      <td>zu den wesentlichen regelungen des gesetzes ge...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>78</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Außerdem müssen Ärzte künftig mehr Sprechstund...</td>\n",
       "      <td>außerdem müssen ärzte künftig mehr sprechstund...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>79</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Mehr Geld für mehr Arbeit</td>\n",
       "      <td>mehr geld für mehr arbeit</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>80</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Für diese zusätzlichen Leistungen sollen die Ä...</td>\n",
       "      <td>für diese zusätzlichen leistungen sollen die ä...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>81</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Darüber hinaus gibt es gestaffelte Zuschläge a...</td>\n",
       "      <td>darüber hinaus gibt es gestaffelte zuschläge a...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>82</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Um die Versorgung auf dem Land zu verbessern, ...</td>\n",
       "      <td>um die versorgung auf dem land zu verbessern w...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>83</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Belohnt wird, wer zuerst zum Hausarzt geht</td>\n",
       "      <td>belohnt wird wer zuerst zum hausarzt geht</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>84</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Versicherte, die an Wahltarifen zur hausarztze...</td>\n",
       "      <td>versicherte die an wahltarifen zur hausarztzen...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>85</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Um den Einfluss von reinen Kapitalinvestoren a...</td>\n",
       "      <td>um den einfluss von reinen kapitalinvestoren a...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>86</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Nichtärztliche Dialyseanbieter dürfen auch wei...</td>\n",
       "      <td>nichtärztliche dialyseanbieter dürfen auch wei...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>87</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Um die Niederlassung für Ärzte attraktiver zu ...</td>\n",
       "      <td>um die niederlassung für ärzte attraktiver zu ...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>88</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Das TSVG enthält zudem in einigen Bereichen Le...</td>\n",
       "      <td>das tsvg enthält zudem in einigen bereichen le...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>89</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Die Ausschreibungen der Krankenkassen für Hilf...</td>\n",
       "      <td>die ausschreibungen der krankenkassen für hilf...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>90</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Heilmittelerbringer wie Physio- und Ergotherap...</td>\n",
       "      <td>heilmittelerbringer wie physio und ergotherape...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>91</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Elektronische Patientenakte muss spätestens 20...</td>\n",
       "      <td>elektronische patientenakte muss spätestens 20...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>92</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Vorantreiben will Minister Spahn mit dem TSVG ...</td>\n",
       "      <td>vorantreiben will minister spahn mit dem tsvg ...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>93</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Patienten sollen auch mit Smartphone oder Tabl...</td>\n",
       "      <td>patienten sollen auch mit smartphone oder tabl...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>94</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>„Das TSVG macht die Versorgung schneller, bess...</td>\n",
       "      <td>das tsvg macht die versorgung schneller besser...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>95</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Aber wenn diese seit 15 Jahren nicht in der La...</td>\n",
       "      <td>aber wenn diese seit 15 jahren nicht in der la...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>96</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>„Das TSVG ist der Einstieg in den Ausstieg aus...</td>\n",
       "      <td>das tsvg ist der einstieg in den ausstieg aus ...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>97</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Der stellvertretende Fraktionsvorsitzende der ...</td>\n",
       "      <td>der stellvertretende fraktionsvorsitzende der ...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>98</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Opposition kritisiert Inhalte und Gesetzgebung...</td>\n",
       "      <td>opposition kritisiert inhalte und gesetzgebung...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>99</td>\n",
       "      <td>Avibactam/Ceftazidim</td>\n",
       "      <td>Zavizefta</td>\n",
       "      <td>2017</td>\n",
       "      <td>2</td>\n",
       "      <td>Bundestag verabschiedet Terminservice- und Ver...</td>\n",
       "      <td>2019-03-14 00:00:00</td>\n",
       "      <td>https://www.aerzteblatt.de/nachrichten/101589/...</td>\n",
       "      <td>13</td>\n",
       "      <td>Als größte Oppositionsfraktion kritisierte die...</td>\n",
       "      <td>als größte oppositionsfraktion kritisierte die...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2015-05-01Vorti</td>\n",
       "      <td>8/3/15</td>\n",
       "      <td>10/15/15</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 15 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    index             substance    product  year  month  \\\n",
       "0       0             Alectinib   Alecensa  2017      5   \n",
       "1       1             Alectinib   Alecensa  2017      5   \n",
       "2       2             Alectinib   Alecensa  2017      5   \n",
       "3       3             Alectinib   Alecensa  2017      5   \n",
       "4       4          Atezolizumab  Tecentriq  2017     10   \n",
       "5       5          Atezolizumab  Tecentriq  2017     10   \n",
       "6       6          Atezolizumab  Tecentriq  2017     10   \n",
       "7       7          Atezolizumab  Tecentriq  2017     10   \n",
       "8       8          Atezolizumab  Tecentriq  2017     10   \n",
       "9       9          Atezolizumab  Tecentriq  2017     10   \n",
       "10     10          Atezolizumab  Tecentriq  2017     10   \n",
       "11     11          Atezolizumab  Tecentriq  2017     10   \n",
       "12     12          Atezolizumab  Tecentriq  2017     10   \n",
       "13     13          Atezolizumab  Tecentriq  2017     10   \n",
       "14     14          Atezolizumab  Tecentriq  2017     10   \n",
       "15     15          Atezolizumab  Tecentriq  2017     10   \n",
       "16     16          Atezolizumab  Tecentriq  2017     10   \n",
       "17     17          Atezolizumab  Tecentriq  2017     10   \n",
       "18     18          Atezolizumab  Tecentriq  2017     10   \n",
       "19     19          Atezolizumab  Tecentriq  2017     10   \n",
       "20     20          Atezolizumab  Tecentriq  2017     10   \n",
       "21     21          Atezolizumab  Tecentriq  2017     10   \n",
       "22     22          Atezolizumab  Tecentriq  2017     10   \n",
       "23     23          Atezolizumab  Tecentriq  2017     10   \n",
       "24     24              Avelumab   Bavencio  2017     10   \n",
       "25     25              Avelumab   Bavencio  2017     10   \n",
       "26     26              Avelumab   Bavencio  2017     10   \n",
       "27     27              Avelumab   Bavencio  2017     10   \n",
       "28     28              Avelumab   Bavencio  2017     10   \n",
       "29     29              Avelumab   Bavencio  2017     10   \n",
       "..    ...                   ...        ...   ...    ...   \n",
       "70     70              Avelumab   Bavencio  2017     10   \n",
       "71     71              Avelumab   Bavencio  2017     10   \n",
       "72     72              Avelumab   Bavencio  2017     10   \n",
       "73     73              Avelumab   Bavencio  2017     10   \n",
       "74     74              Avelumab   Bavencio  2017     10   \n",
       "75     75              Avelumab   Bavencio  2017     10   \n",
       "76     76  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "77     77  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "78     78  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "79     79  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "80     80  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "81     81  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "82     82  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "83     83  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "84     84  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "85     85  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "86     86  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "87     87  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "88     88  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "89     89  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "90     90  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "91     91  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "92     92  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "93     93  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "94     94  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "95     95  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "96     96  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "97     97  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "98     98  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "99     99  Avibactam/Ceftazidim  Zavizefta  2017      2   \n",
       "\n",
       "                                                title       date_published  \\\n",
       "0                  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "1                  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "2                  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "3                  Neue Arzneimittel treiben Roche an  2018-10-17 00:00:00   \n",
       "4   Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "5   Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "6   Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "7   Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "8   Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "9   Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "10  Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "11  Durvalumab verlängert progressionsfreies Überl...  2017-09-12 00:00:00   \n",
       "12  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "13  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "14  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "15  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "16  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "17  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "18  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "19  Checkpoint-Inhibitor Atezolizumab verlängert L...  2016-12-15 00:00:00   \n",
       "20  FDA und EMA warnen vor unkritischem Einsatz vo...  2018-06-06 00:00:00   \n",
       "21  FDA und EMA warnen vor unkritischem Einsatz vo...  2018-06-06 00:00:00   \n",
       "22  FDA und EMA warnen vor unkritischem Einsatz vo...  2018-06-06 00:00:00   \n",
       "23  FDA und EMA warnen vor unkritischem Einsatz vo...  2018-06-06 00:00:00   \n",
       "24             Merck erhält EU-Zulassung für Bavencio  2017-09-22 00:00:00   \n",
       "25             Merck erhält EU-Zulassung für Bavencio  2017-09-22 00:00:00   \n",
       "26             Merck erhält EU-Zulassung für Bavencio  2017-09-22 00:00:00   \n",
       "27             Merck erhält EU-Zulassung für Bavencio  2017-09-22 00:00:00   \n",
       "28  Warum die Krebsimmuntherapie nicht immer erfol...  2017-08-08 00:00:00   \n",
       "29  Warum die Krebsimmuntherapie nicht immer erfol...  2017-08-08 00:00:00   \n",
       "..                                                ...                  ...   \n",
       "70  Neue Zielstruktur für Immuntherapie von solide...  2012-06-03 00:00:00   \n",
       "71  Neue Zielstruktur für Immuntherapie von solide...  2012-06-03 00:00:00   \n",
       "72  Neue Zielstruktur für Immuntherapie von solide...  2012-06-03 00:00:00   \n",
       "73                 Merck bleibt optimistisch für 2019  2018-10-16 00:00:00   \n",
       "74                 Merck bleibt optimistisch für 2019  2018-10-16 00:00:00   \n",
       "75                 Merck bleibt optimistisch für 2019  2018-10-16 00:00:00   \n",
       "76  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "77  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "78  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "79  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "80  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "81  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "82  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "83  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "84  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "85  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "86  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "87  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "88  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "89  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "90  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "91  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "92  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "93  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "94  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "95  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "96  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "97  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "98  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "99  Bundestag verabschiedet Terminservice- und Ver...  2019-03-14 00:00:00   \n",
       "\n",
       "                                                  url  text_index  \\\n",
       "0   https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "1   https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "2   https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "3   https://www.aerzteblatt.de/nachrichten/98565/N...           0   \n",
       "4   https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "5   https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "6   https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "7   https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "8   https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "9   https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "10  https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "11  https://www.aerzteblatt.de/nachrichten/78195/L...           1   \n",
       "12  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "13  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "14  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "15  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "16  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "17  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "18  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "19  https://www.aerzteblatt.de/nachrichten/72033/C...           2   \n",
       "20  https://www.aerzteblatt.de/nachrichten/95632/U...           4   \n",
       "21  https://www.aerzteblatt.de/nachrichten/95632/U...           4   \n",
       "22  https://www.aerzteblatt.de/nachrichten/95632/U...           4   \n",
       "23  https://www.aerzteblatt.de/nachrichten/95632/U...           4   \n",
       "24  https://www.aerzteblatt.de/nachrichten/79448/M...           5   \n",
       "25  https://www.aerzteblatt.de/nachrichten/79448/M...           5   \n",
       "26  https://www.aerzteblatt.de/nachrichten/79448/M...           5   \n",
       "27  https://www.aerzteblatt.de/nachrichten/79448/M...           5   \n",
       "28  https://www.aerzteblatt.de/nachrichten/77491/W...           6   \n",
       "29  https://www.aerzteblatt.de/nachrichten/77491/W...           6   \n",
       "..                                                ...         ...   \n",
       "70  https://www.aerzteblatt.de/nachrichten/50395/N...          11   \n",
       "71  https://www.aerzteblatt.de/nachrichten/50395/N...          11   \n",
       "72  https://www.aerzteblatt.de/nachrichten/50395/N...          11   \n",
       "73  https://www.aerzteblatt.de/nachrichten/98519/M...          12   \n",
       "74  https://www.aerzteblatt.de/nachrichten/98519/M...          12   \n",
       "75  https://www.aerzteblatt.de/nachrichten/98519/M...          12   \n",
       "76  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "77  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "78  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "79  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "80  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "81  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "82  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "83  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "84  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "85  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "86  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "87  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "88  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "89  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "90  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "91  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "92  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "93  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "94  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "95  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "96  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "97  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "98  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "99  https://www.aerzteblatt.de/nachrichten/101589/...          13   \n",
       "\n",
       "                                                 text  \\\n",
       "0   Basel – Der Schweizer Pharmakonzern Roche blei...   \n",
       "1   Der Pharmakonzern peilt im Gesamtjahr ein Umsa...   \n",
       "2   Zwischen Januar und September legte der Umsatz...   \n",
       "3   In einer Telefonkonferenz stellte Schwan klar,...   \n",
       "4   Tampa/Florida – Der PD-L1-Inhibitor Durvalumab...   \n",
       "5   Bei einem Drittel aller Patienten mit NSCLC wi...   \n",
       "6   Die PACIFIC-Studie hat untersucht, ob in diese...   \n",
       "7   Die beiden primären Endpunkte der Studie waren...   \n",
       "8   Nach zwölf Monaten waren im Durvalumab-Arm noc...   \n",
       "9   Eine lebensverlängernde Wirkung konnte (noch) ...   \n",
       "10  Dies sind für ein fortgeschrittenes Bronchialk...   \n",
       "11  Die Verträglichkeit von Durvalumab war für die...   \n",
       "12  Sacramento – Der monoklonale Antikörper Atezol...   \n",
       "13  Atezolizumab bindet am Programmed Cell Death L...   \n",
       "14  Der Antikörper gehört damit zu einer Gruppe vo...   \n",
       "15  Nivolumab und Pembrolizumab sind bereits erfol...   \n",
       "16  Jetzt liegen die Ergebnisse der entsprechenden...   \n",
       "17  Eine Besonderheit der Studienergebnisse ist, d...   \n",
       "18  Atezolizumab wurde aufgrund der Ergebnisse der...   \n",
       "19  Atezolizumab ist deutlich besser verträglich a...   \n",
       "20  Silver Spring/London – Die beiden Checkpointin...   \n",
       "21  Pembrolizumab und Atezolizumab verdanken ihre ...   \n",
       "22  Beide Studien verglichen die Checkpointinhibit...   \n",
       "23  FDA und EMA warnen deshalb vor dem Einsatz der...   \n",
       "24  Darmstadt – Der Darmstädter Chemie- und Pharma...   \n",
       "25  Erste Markteinführungen seien in Deutschland u...   \n",
       "26  Bavencio ist der größte Hoffnungsträger in der...   \n",
       "27  Die EU-Freigabe des Medikaments, das Merck zus...   \n",
       "28  Bethesda – Ein aufwendiges Screening aller bek...   \n",
       "29  Die Immuntherapie hat die Behandlung von Krebs...   \n",
       "..                                                ...   \n",
       "70  Auch die Blockade der Interaktion von PD-1 mit...   \n",
       "71  Die objektiven Ansprechraten lagen zwischen se...   \n",
       "72  Der Anti-PD-1-Antikörper sei im allgemeinen gu...   \n",
       "73  Darmstadt – Der Darmstädter Merck-Konzern setz...   \n",
       "74  Ab dem kommenden Jahr erwarte der Dax-Konzern ...   \n",
       "75  In seinem zuletzt schwächelnden Geschäft mit S...   \n",
       "76  Berlin – Schnellere Arzttermine für gesetzlich...   \n",
       "77  Zu den wesentlichen Regelungen des Gesetzes ge...   \n",
       "78  Außerdem müssen Ärzte künftig mehr Sprechstund...   \n",
       "79                          Mehr Geld für mehr Arbeit   \n",
       "80  Für diese zusätzlichen Leistungen sollen die Ä...   \n",
       "81  Darüber hinaus gibt es gestaffelte Zuschläge a...   \n",
       "82  Um die Versorgung auf dem Land zu verbessern, ...   \n",
       "83         Belohnt wird, wer zuerst zum Hausarzt geht   \n",
       "84  Versicherte, die an Wahltarifen zur hausarztze...   \n",
       "85  Um den Einfluss von reinen Kapitalinvestoren a...   \n",
       "86  Nichtärztliche Dialyseanbieter dürfen auch wei...   \n",
       "87  Um die Niederlassung für Ärzte attraktiver zu ...   \n",
       "88  Das TSVG enthält zudem in einigen Bereichen Le...   \n",
       "89  Die Ausschreibungen der Krankenkassen für Hilf...   \n",
       "90  Heilmittelerbringer wie Physio- und Ergotherap...   \n",
       "91  Elektronische Patientenakte muss spätestens 20...   \n",
       "92  Vorantreiben will Minister Spahn mit dem TSVG ...   \n",
       "93  Patienten sollen auch mit Smartphone oder Tabl...   \n",
       "94  „Das TSVG macht die Versorgung schneller, bess...   \n",
       "95  Aber wenn diese seit 15 Jahren nicht in der La...   \n",
       "96  „Das TSVG ist der Einstieg in den Ausstieg aus...   \n",
       "97  Der stellvertretende Fraktionsvorsitzende der ...   \n",
       "98  Opposition kritisiert Inhalte und Gesetzgebung...   \n",
       "99  Als größte Oppositionsfraktion kritisierte die...   \n",
       "\n",
       "                                           text_lower  label            ebaid  \\\n",
       "0   basel  der schweizer pharmakonzern roche bleib...    3.0  2017-05-01Alect   \n",
       "1   der pharmakonzern peilt im gesamtjahr ein umsa...    3.0  2017-05-01Alect   \n",
       "2   zwischen januar und september legte der umsatz...    3.0  2017-05-01Alect   \n",
       "3   in einer telefonkonferenz stellte schwan klar ...    3.0  2017-05-01Alect   \n",
       "4   tampaflorida  der pdl1inhibitor durvalumab der...    3.0  2017-10-01Atez2   \n",
       "5   bei einem drittel aller patienten mit nsclc wi...    2.0  2017-10-01Atez2   \n",
       "6   die pacificstudie hat untersucht ob in dieser ...    3.0  2017-10-01Atez2   \n",
       "7   die beiden primären endpunkte der studie waren...    3.0  2017-10-01Atez2   \n",
       "8   nach zwölf monaten waren im durvalumabarm noch...    3.0  2017-10-01Atez2   \n",
       "9   eine lebensverlängernde wirkung konnte noch ni...    3.0  2017-10-01Atez2   \n",
       "10  dies sind für ein fortgeschrittenes bronchialk...    3.0  2017-10-01Atez2   \n",
       "11  die verträglichkeit von durvalumab war für die...    3.0  2017-10-01Atez2   \n",
       "12  sacramento  der monoklonale antikörper atezoli...    3.0  2017-10-01Atez2   \n",
       "13  atezolizumab bindet am programmed cell death l...    3.0  2017-10-01Atez2   \n",
       "14  der antikörper gehört damit zu einer gruppe vo...    3.0  2017-10-01Atez2   \n",
       "15  nivolumab und pembrolizumab sind bereits erfol...    3.0  2017-10-01Atez2   \n",
       "16  jetzt liegen die ergebnisse der entsprechenden...    2.0  2017-10-01Atez2   \n",
       "17  eine besonderheit der studienergebnisse ist da...    2.0  2017-10-01Atez2   \n",
       "18  atezolizumab wurde aufgrund der ergebnisse der...    3.0  2017-10-01Atez2   \n",
       "19  atezolizumab ist deutlich besser verträglich a...    3.0  2017-10-01Atez2   \n",
       "20  silver springlondon  die beiden checkpointinhi...    3.0  2017-10-01Atez2   \n",
       "21  pembrolizumab und atezolizumab verdanken ihre ...    3.0  2017-10-01Atez2   \n",
       "22  beide studien verglichen die checkpointinhibit...    3.0  2017-10-01Atez2   \n",
       "23  fda und ema warnen deshalb vor dem einsatz der...    3.0  2017-10-01Atez2   \n",
       "24  darmstadt  der darmstädter chemie und pharmako...    3.0  2017-10-01Avelu   \n",
       "25  erste markteinführungen seien in deutschland u...    3.0  2017-10-01Avelu   \n",
       "26  bavencio ist der größte hoffnungsträger in der...    3.0  2017-10-01Avelu   \n",
       "27  die eufreigabe des medikaments das merck zusam...    3.0  2017-10-01Avelu   \n",
       "28  bethesda  ein aufwendiges screening aller beka...    3.0  2017-10-01Avelu   \n",
       "29  die immuntherapie hat die behandlung von krebs...    3.0  2017-10-01Avelu   \n",
       "..                                                ...    ...              ...   \n",
       "70  auch die blockade der interaktion von pd1 mit ...    2.0  2017-10-01Avelu   \n",
       "71  die objektiven ansprechraten lagen zwischen se...    3.0  2017-10-01Avelu   \n",
       "72  der antipd1antikörper sei im allgemeinen gut v...    3.0  2017-10-01Avelu   \n",
       "73  darmstadt  der darmstädter merckkonzern setzt ...    3.0  2017-10-01Avelu   \n",
       "74  ab dem kommenden jahr erwarte der daxkonzern s...    3.0  2017-10-01Avelu   \n",
       "75  in seinem zuletzt schwächelnden geschäft mit s...    2.0  2017-10-01Avelu   \n",
       "76  berlin  schnellere arzttermine für gesetzlich ...    2.0  2015-05-01Vorti   \n",
       "77  zu den wesentlichen regelungen des gesetzes ge...    2.0  2015-05-01Vorti   \n",
       "78  außerdem müssen ärzte künftig mehr sprechstund...    2.0  2015-05-01Vorti   \n",
       "79                          mehr geld für mehr arbeit    3.0  2015-05-01Vorti   \n",
       "80  für diese zusätzlichen leistungen sollen die ä...    2.0  2015-05-01Vorti   \n",
       "81  darüber hinaus gibt es gestaffelte zuschläge a...    2.0  2015-05-01Vorti   \n",
       "82  um die versorgung auf dem land zu verbessern w...    2.0  2015-05-01Vorti   \n",
       "83          belohnt wird wer zuerst zum hausarzt geht    3.0  2015-05-01Vorti   \n",
       "84  versicherte die an wahltarifen zur hausarztzen...    2.0  2015-05-01Vorti   \n",
       "85  um den einfluss von reinen kapitalinvestoren a...    2.0  2015-05-01Vorti   \n",
       "86  nichtärztliche dialyseanbieter dürfen auch wei...    3.0  2015-05-01Vorti   \n",
       "87  um die niederlassung für ärzte attraktiver zu ...    2.0  2015-05-01Vorti   \n",
       "88  das tsvg enthält zudem in einigen bereichen le...    2.0  2015-05-01Vorti   \n",
       "89  die ausschreibungen der krankenkassen für hilf...    2.0  2015-05-01Vorti   \n",
       "90  heilmittelerbringer wie physio und ergotherape...    2.0  2015-05-01Vorti   \n",
       "91  elektronische patientenakte muss spätestens 20...    2.0  2015-05-01Vorti   \n",
       "92  vorantreiben will minister spahn mit dem tsvg ...    2.0  2015-05-01Vorti   \n",
       "93  patienten sollen auch mit smartphone oder tabl...    2.0  2015-05-01Vorti   \n",
       "94  das tsvg macht die versorgung schneller besser...    2.0  2015-05-01Vorti   \n",
       "95  aber wenn diese seit 15 jahren nicht in der la...    2.0  2015-05-01Vorti   \n",
       "96  das tsvg ist der einstieg in den ausstieg aus ...    2.0  2015-05-01Vorti   \n",
       "97  der stellvertretende fraktionsvorsitzende der ...    3.0  2015-05-01Vorti   \n",
       "98  opposition kritisiert inhalte und gesetzgebung...    1.0  2015-05-01Vorti   \n",
       "99  als größte oppositionsfraktion kritisierte die...    1.0  2015-05-01Vorti   \n",
       "\n",
       "   dpublication ddecision  \n",
       "0        8/1/17  10/19/17  \n",
       "1        8/1/17  10/19/17  \n",
       "2        8/1/17  10/19/17  \n",
       "3        8/1/17  10/19/17  \n",
       "4        1/2/18   3/16/18  \n",
       "5        1/2/18   3/16/18  \n",
       "6        1/2/18   3/16/18  \n",
       "7        1/2/18   3/16/18  \n",
       "8        1/2/18   3/16/18  \n",
       "9        1/2/18   3/16/18  \n",
       "10       1/2/18   3/16/18  \n",
       "11       1/2/18   3/16/18  \n",
       "12       1/2/18   3/16/18  \n",
       "13       1/2/18   3/16/18  \n",
       "14       1/2/18   3/16/18  \n",
       "15       1/2/18   3/16/18  \n",
       "16       1/2/18   3/16/18  \n",
       "17       1/2/18   3/16/18  \n",
       "18       1/2/18   3/16/18  \n",
       "19       1/2/18   3/16/18  \n",
       "20       1/2/18   3/16/18  \n",
       "21       1/2/18   3/16/18  \n",
       "22       1/2/18   3/16/18  \n",
       "23       1/2/18   3/16/18  \n",
       "24       1/2/18   3/16/18  \n",
       "25       1/2/18   3/16/18  \n",
       "26       1/2/18   3/16/18  \n",
       "27       1/2/18   3/16/18  \n",
       "28       1/2/18   3/16/18  \n",
       "29       1/2/18   3/16/18  \n",
       "..          ...       ...  \n",
       "70       1/2/18   3/16/18  \n",
       "71       1/2/18   3/16/18  \n",
       "72       1/2/18   3/16/18  \n",
       "73       1/2/18   3/16/18  \n",
       "74       1/2/18   3/16/18  \n",
       "75       1/2/18   3/16/18  \n",
       "76       8/3/15  10/15/15  \n",
       "77       8/3/15  10/15/15  \n",
       "78       8/3/15  10/15/15  \n",
       "79       8/3/15  10/15/15  \n",
       "80       8/3/15  10/15/15  \n",
       "81       8/3/15  10/15/15  \n",
       "82       8/3/15  10/15/15  \n",
       "83       8/3/15  10/15/15  \n",
       "84       8/3/15  10/15/15  \n",
       "85       8/3/15  10/15/15  \n",
       "86       8/3/15  10/15/15  \n",
       "87       8/3/15  10/15/15  \n",
       "88       8/3/15  10/15/15  \n",
       "89       8/3/15  10/15/15  \n",
       "90       8/3/15  10/15/15  \n",
       "91       8/3/15  10/15/15  \n",
       "92       8/3/15  10/15/15  \n",
       "93       8/3/15  10/15/15  \n",
       "94       8/3/15  10/15/15  \n",
       "95       8/3/15  10/15/15  \n",
       "96       8/3/15  10/15/15  \n",
       "97       8/3/15  10/15/15  \n",
       "98       8/3/15  10/15/15  \n",
       "99       8/3/15  10/15/15  \n",
       "\n",
       "[100 rows x 15 columns]"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ds_T = dataset_short.set_index('substance').T.to_dict('list')\n",
    "\n",
    "l =[]\n",
    "for i, substance in enumerate(dataset['substance'].tolist()):\n",
    "    l.append(ds_T[substance])\n",
    "dataset[\"ebaid\"] = [item[0] for item in l]\n",
    "dataset[\"dpublication\"] = [item[1] for item in l]\n",
    "dataset[\"ddecision\"] = [item[2] for item in l]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataset.to_csv(\"new_dataset.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
